Diabetes-Induced Changes in Macrophage Biology Might Lead to Reduced Risk for Abdominal Aortic Aneurysm Development.

inflammation macrophages metabolism type 2 diabetes

Journal

Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790

Informations de publication

Date de publication:
29 Jan 2022
Historique:
received: 17 12 2021
revised: 21 01 2022
accepted: 26 01 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

Type 2 diabetes patients are less likely to develop an abdominal aortic aneurysm (AAA). Since macrophages play a crucial role in AAA development, we hypothesized that this decrease in AAA risk in diabetic patients might be due to diabetes-induced changes in macrophage biology. To test this hypothesis, we treated primary macrophages obtained from healthy human volunteers with serum from non-diabetic vs. diabetic AAA patients and observed differences in extracellular acidification and the expression of genes involved in glycolysis and lipid oxidation. These results suggest an increase in metabolism in macrophages treated with serum from diabetic AAA patients. Since serum samples used did not differ in glucose content, these changes are not likely to be caused by differences in glycemia. Macrophage functions have been shown to be linked to their metabolism. In line with this, our data suggest that this increase in macrophage metabolism is accompanied by a shift towards an anti-inflammatory state. Together, these results support a model where diabetes-induced changes in metabolism in macrophages might lead to a reduced risk for AAA development.

Identifiants

pubmed: 35208203
pii: metabo12020128
doi: 10.3390/metabo12020128
pmc: PMC8879155
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Société de chirurgie vasculaire et endovasculaire de langue française (SCVE)
ID : 2019-00009
Organisme : Agence Nationale de la Recherche
ID : ANR-16-CE14-0001-01

Références

Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2605-13
pubmed: 16973970
Int J Obes (Lond). 2007 Sep;31(9):1420-8
pubmed: 17593905
Biochim Biophys Acta. 2015 Feb;1847(2):171-181
pubmed: 25449966
Diab Vasc Dis Res. 2016 Sep;13(5):341-7
pubmed: 27334484
J Vasc Surg. 2016 Jul;64(1):46-54.e8
pubmed: 27106243
Eur J Vasc Endovasc Surg. 2007 May;33(5):599-604
pubmed: 17307366
J Innate Immun. 2022;14(1):51-68
pubmed: 34247159
Int J Cardiol. 2014 Mar 1;172(1):179-84
pubmed: 24456889
Biomark Res. 2021 Jan 6;9(1):1
pubmed: 33407885
Diabetologia. 2016 Oct;59(10):2134-44
pubmed: 27421726
J Vasc Surg. 2010 Jul;52(1):55-61.e2
pubmed: 20620765
Nat Med. 2003 Feb;9(2):213-9
pubmed: 12524534
Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):431-8
pubmed: 23241402
Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2171-2181
pubmed: 28912363
Mediators Inflamm. 2015;2015:816460
pubmed: 26089604
Biochem Med (Zagreb). 2018 Oct 15;28(3):030702
pubmed: 30429669
Vasc Endovascular Surg. 2018 Nov;52(8):597-601
pubmed: 29940819
Circulation. 2008 Feb 12;117(6):806-15
pubmed: 18227385
Cardiovasc Res. 2018 Nov 1;114(13):1702-1713
pubmed: 30052821
Nat Rev Cardiol. 2017 Aug;14(8):457-471
pubmed: 28406184
Mol Cell Endocrinol. 2018 Feb 5;461:256-264
pubmed: 28935544
Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1746-55
pubmed: 26044582
Immunity. 2017 Sep 19;47(3):406-420
pubmed: 28930657
J Leukoc Biol. 2019 Aug;106(2):345-358
pubmed: 30576000
J Transl Med. 2018 Dec 13;16(1):354
pubmed: 30545380
Arterioscler Thromb Vasc Biol. 2017 Apr;37(4):730-736
pubmed: 28183702
Arterioscler Thromb Vasc Biol. 2017 Apr;37(4):613-621
pubmed: 28183700
Nat Rev Cardiol. 2021 Dec;18(12):809-823
pubmed: 34127848
PLoS One. 2010 Sep 20;5(9):e12828
pubmed: 20877467
Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1075-7
pubmed: 20484703

Auteurs

Giulia Chinetti (G)

Centre Hospitalier Universitaire (CHU), Institut National de la Santé Et de la Recherche Médicale (INSERM), Centre Méditerranéen de Médecine Moléculaire (C3M), Université Côte d'Azur, 06200 Nice, France.

Joseph Carboni (J)

Department of Vascular Surgery, Centre Hospitalier Universitaire (CHU), 06000 Nice, France.

Joseph Murdaca (J)

Institut National de la Santé Et de la Recherche Médicale (INSERM), Centre Méditerranéen de Médecine Moléculaire (C3M), Université Côte d'Azur, 06200 Nice, France.

Claudine Moratal (C)

Institut National de la Santé Et de la Recherche Médicale (INSERM), Centre Méditerranéen de Médecine Moléculaire (C3M), Université Côte d'Azur, 06200 Nice, France.

Brigitte Sibille (B)

Institut National de la Santé Et de la Recherche Médicale (INSERM), Centre Méditerranéen de Médecine Moléculaire (C3M), Université Côte d'Azur, 06200 Nice, France.

Juliette Raffort (J)

Centre Hospitalier Universitaire (CHU), Institut National de la Santé Et de la Recherche Médicale (INSERM), Centre Méditerranéen de Médecine Moléculaire (C3M), Université Côte d'Azur, 06200 Nice, France.

Fabien Lareyre (F)

Institut National de la Santé Et de la Recherche Médicale (INSERM), Centre Méditerranéen de Médecine Moléculaire (C3M), Université Côte d'Azur, 06200 Nice, France.
Department of Vascular Surgery, Hospital of Antibes Juan-les-Pins, 06160 Antibes, France.

Elixène Jean Baptiste (EJ)

Centre Hospitalier Universitaire (CHU), Institut National de la Santé Et de la Recherche Médicale (INSERM), Centre Méditerranéen de Médecine Moléculaire (C3M), Université Côte d'Azur, 06200 Nice, France.

Réda Hassen-Khodja (R)

Centre Hospitalier Universitaire (CHU), Institut National de la Santé Et de la Recherche Médicale (INSERM), Centre Méditerranéen de Médecine Moléculaire (C3M), Université Côte d'Azur, 06200 Nice, France.

Jaap G Neels (JG)

Institut National de la Santé Et de la Recherche Médicale (INSERM), Centre Méditerranéen de Médecine Moléculaire (C3M), Université Côte d'Azur, 06200 Nice, France.

Classifications MeSH